Healthcare -
Biotechnology - NASDAQ - US
$ 2.47
3.78 %
$ 119 M
Market Cap
-1.79
P/E
SAVA - STOCK-BASED COMPENSATION
Stock-based Compensation SAVA - Cassava Sciences, Inc.
4.59 M
LAST VALUE
61.47%
2 YEAR CAGR
13.94%
5 YEAR CAGR
3.99%
10 YEAR CAGR